Most Read News
- James C. Smith elected to Pfizer's Board of Directors
- Sanofi and Medtronic to form strategic alliance
- Diabetes drug appears to work for weight management, reversing prediabetes
- Abbott to acquire Veropharm
- Boehringer Ingelheim Statement on Hepatitis C drug development
- Is the next 'new' cancer drug already in your medicine cabinet?
- FDA issues guidance to support the responsible development of nanotechnology products
Company Profiles and News
Abbott |
Amgen |
AstraZeneca |
Bayer |
Boehringer Ingelheim |
Bristol-Myers Squibb |
Daiichi Sankyo |
Eli Lilly and Company |
Genzyme |
GlaxoSmithKline |
Lundbeck |
Merck |
Merck KGaA |
Novartis |
Novo Nordisk |
Nycomed |
Pfizer |
Roche |
Sanofi |
Shire |
Takeda |
UCB | ...
Showcase your Company Profile / News
Showcase your Company Profile / News
Pharmaceutical Companies
Business & Industry News
- MedImmune and Advaxis partner on immuno-oncology combination clinical trial
- AstraZeneca reveals designs for new Global R&D Centre and Corporate Headquarters in Cambridge, UK
- Novartis maintained strong innovation momentum in second quarter
- Pfizer to Acquire InnoPharma, Inc.
- Novartis to license Google "smart lens" technology
- Abbott to sell its developed markets branded generics pharmaceuticals business to Mylan
- CliniWorks forms a strategic alliance with Pfizer
Research & Development News
- Niacin too dangerous for routine cholesterol therapy
- Taking B vitamins won't prevent Alzheimer's disease
- Scientists find genetic recipe to turn stem cells to blood
- Patient-specific stem cells and personalized gene therapy
- New technologies fuel patient participation and data collection in research
- Cleveland Clinic researchers identify urgent need for Alzheimer's drug development
- Drug shows promise for effectively treating metabolic syndrome
Regulatory Affairs News
- FDA issues guidance to support the responsible development of nanotechnology products
- FDA launches openFDA to provide easy access to valuable FDA public data
- FDA requires removal of certain restrictions on the diabetes drug Avandia
- EMA and US FDA release first conclusions of parallel assessment of quality-by-design applications
- FDA approves new drug to treat HIV infection
- FDA alerts companies to stop illegal sale of treatments for diabetes
- FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies